Medical Equipment

One of the primary drivers of the Cell Therapy Bioreactors Market is increasing demand for gene therapies supported by advancements in genetic sequencing

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Cell Therapy Bioreactors Market At The End Of The 2026–2030 Forecast Period?

The cell therapy bioreactors market has experienced rapid expansion in its size during recent years. It is projected to grow from $1.24 billion in 2025 to $1.44 billion in 2026, at a compound annual growth rate (CAGR) of 16.3%. The market’s growth in the past can be attributed to the rising demand for cell-based therapies, increased investment in regenerative medicine, the growing adoption of automated cell culture systems, the broadening scope of stem cell research, and the escalating need for scalable cell production.

The cell therapy bioreactors market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $2.61 billion by 2030, driven by a compound annual growth rate (CAGR) of 16.0%. Factors contributing to this growth during the forecast period include the increasing adoption of cell therapy bioreactors within manufacturing processes, heightened investment in advanced bioprocessing technologies, a greater emphasis on optimizing processes and ensuring quality control, the broadening scope of clinical trials incorporating cell therapies, and the expanding need for personalized medicine solutions. Key developments expected over the forecast period encompass progress in automated cell culture technologies, novel bioreactor designs for improved scalability, advancements in platforms for stem cell expansion, ongoing research and development into systems for process monitoring and control, and emerging enhancements in integrated manufacturing solutions for cell therapy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30550&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Cell Therapy Bioreactors Market?

The expanding demand for gene therapies is anticipated to boost the growth of the cell therapy bioreactors market in the future. Gene therapy is a medical method focused on altering or replacing faulty genes to treat or prevent diseases. The rising interest in gene therapy stems from progress in genetic sequencing and diagnostics, which allow for precise identification of disease-causing genes for targeted treatments. Cell therapy bioreactors facilitate gene therapies by offering optimal conditions for the multiplication, modification, and expansion of therapeutic cells. They improve treatment creation and scalability by ensuring uniform cell quality, enhancing efficiency, and supporting quicker production of individualized gene-based therapies. For instance, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, an increase from 5 approvals in 2022. Consequently, the increasing demand for gene therapies is propelling the expansion of the cell therapy bioreactors market. The increasing prevalence of chronic and rare diseases is expected to fuel the growth of the cell therapy bioreactors market due to the rising demand for advanced cell-based therapies. These conditions refer to enduring health issues and uncommon disorders that frequently necessitate specialized therapeutic approaches, including personalized and regenerative treatments. The rise in chronic diseases is largely attributable to unhealthy lifestyles, such as poor diet, lack of physical activity, and smoking, which elevate the risk of conditions like diabetes, heart disease, and obesity. Cell therapy bioreactors aid in managing chronic diseases by providing controlled environments for the cultivation and expansion of therapeutic cells. They enhance treatment efficacy and scalability through consistent cell quality, enabling customized therapies, and supporting long-term patient care. For example, in 2025, the International Diabetes Federation, a Belgium-based health organization, stated that in 2024, approximately 589 million adults aged 20-79 were living with diabetes, with this total projected to reach 853 million by 2050. Thus, the increasing occurrence of chronic and rare diseases is driving the expansion of the cell therapy bioreactors market.

What Segment Types Make Up The Cell Therapy Bioreactors Market?

The cell therapy bioreactors market covered in this report is segmented –

1) By Product: Stirred Tank Bioreactors, Wave-Induced Bioreactors, Fixed-Bed Bioreactors, Other Products

2) By Cell Type: Stem Cells, Immune Cells, Differentiated Cells, Other Cell Types

3) By Material: Single-Use Bioreactors, Reusable Bioreactors

4) By Application: Research, Clinical, Commercial Production

5) By End-Users: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Manufacturing Organizations (CMOs), Other End Users

Subsegments:

1) By Stirred Tank Bioreactors: Stainless Steel Stirred Tank Systems, Glass Stirred Tank Systems, Single Use Stirred Tank Systems, Automated Stirred Tank Systems

2) By Wave Induced Bioreactors: Rocking Motion Bioreactor Systems, Single Use Wave Bag Systems, Modular Wave Platform Systems, Automated Wave Based Culture Systems

3) By Fixed Bed Bioreactors: Packed Bed Bioreactor Systems, Scaffold Based Fixed Bed Systems, Microcarrier Based Fixed Bed Systems, Perfusion Enabled Fixed Bed Systems

4) By Other Products: Hollow Fiber Bioreactor Systems, Perfusion Bioreactor Systems, Rotary Cell Culture Systems, Microfluidic Bioreactor Systems

Which Market Trends Are Creating New Opportunities In The Cell Therapy Bioreactors Market?

Major companies operating in the cell therapy bioreactors market are dedicating efforts to developing advanced platforms, such as modular, multi-scale bioreactor systems, aimed at improving process scalability, cell expansion efficiency, and consistency across all stages from early research to commercial manufacturing. This type of platform represents an adaptable system allowing researchers to execute parallel small-scale experiments, optimize conditions, and smoothly transition to mid- or large-scale production while ensuring uniform culture environments and high yields. For example, in July 2024, EXO-Harvest, a biomanufacturing technology company based in Belgium, unveiled its innovative multi-scale bioreactor platform, intended for the efficient production of mesenchymal stem cells and extracellular vesicles, thereby supporting scalable adherent cell culture from the discovery phase to industrial production. This platform integrates small-scale multi-bioreactor screening and mid/large-scale systems, designed to accelerate product development, decrease costs, and yield high-quality cultures with precise environmental regulation.

Who Are The Leading Companies Operating In The Cell Therapy Bioreactors Market?

Major companies operating in the cell therapy bioreactors market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Danaher Corporation, Corning Incorporated, Lonza Group, Terumo Corporation, Sartorius AG, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, PBS Biotech Inc., Meissner Filtration Products Inc., Infors AG, Bionet Engineering & Technologies Pvt. Ltd., Wilson Wolf Manufacturing Corporation, Synthecon Incorporated, Cellexus Limited, Celartia Inc., Able Biott Inc., CelVivo ApS

Read the full cell therapy bioreactors market report here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-bioreactors-market-report

Which Region Is Projected To Lead The Cell Therapy Bioreactors Market During The Forecast Period?

North America was the largest region in the cell therapy bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Therapy Bioreactors Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30550&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Bioreactors Market 2026, By The Business Research Company

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Membrane Bioreactor Market Report 2026

https://www.thebusinessresearchcompany.com/report/membrane-bioreactor-global-market-report

cell therapy human raw materials global market report

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795